TC
SCMP

TFS Capital’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

TFS Capital’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-83,694
Closed -$879K – 553
2017
Q2 		$879K Buy
+83,694
New +$853K 0.34% 81
2016
Q3 		– Sell
-160,695
Closed -$1.76M – 1154
2016
Q2 		$1.76M Buy
160,695
+149,162
+1,293% +$1.67M 0.32% 37
2016
Q1 		$126K Sell
11,533
-1,365
-11% -$17.2K 0.02% 854
2015
Q4 		$223K Sell
12,898
-30,420
-70% -$545K 0.02% 574
2015
Q3 		$861K Sell
43,318
-39,042
-47% -$895K 0.08% 376
2015
Q2 		$1.35M Sell
82,360
-5,177
-6% -$89.8K 0.13% 256
2015
Q1 		$1.36M Sell
87,537
-172,140
-66% -$2.67M 0.13% 239
2014
Q4 		$3.71M Buy
+259,677
New +$2.74M 0.35% 48
2014
Q3 		– Sell
-169,994
Closed -$1.17M – 1339
2014
Q2 		$1.17M Sell
169,994
-201,898
-54% -$1.43M 0.09% 352
2014
Q1 		$2.66M Buy
371,892
+222,888
+150% +$1.91M 0.18% 157
2013
Q4 		$1.4M Sell
149,004
-18,793
-11% -$134K 0.07% 431
2013
Q3 		$1.05M Sell
167,797
-217,977
-57% -$1.36M 0.05% 557
2013
Q2 		$2.54M Buy
+385,774
New +$3.06M 0.11% 279

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TFS Capital's SCMP Position: Q3 2017 in Review

TFS Capital sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2017, closing a stake of 83,694 shares — an estimated $879K sold.

TFS Capital first reported a position in SCMP in Q2 2013 and held it in 13 quarters. The position peaked at $3.71M in Q4 2014. 178 funds tracked by Wall St. Rank hold SCMP as of Q3 2017.

  • TFS Capital reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 83,694 Sucampo Pharmaceuticals, Inc. shares in Q3 2017, an estimated $879K.
  • TFS Capital first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 13 quarters.
  • TFS Capital's Sucampo Pharmaceuticals, Inc. position peaked at $3.71M in Q4 2014.
  • 178 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.